{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:25:53Z","timestamp":1794068753808,"version":"4.8.0"},"reference-count":60,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The erythroid growth factor erythropoietin (EPO) is mainly produced by the kidneys in adult mammals and induces expansion of erythroid cells and iron use for hemoglobin synthesis. The liver also produces EPO at a lower level than the kidneys. Renal and hepatic EPO production is fundamentally regulated by hypoxia-inducible transcription factors (HIFs) in a hypoxia\/anemia-inducible manner. Recently, small compounds that activate HIFs and EPO production in the\u00a0kidneys by inhibiting HIF-prolyl hydroxylases (HIF-PHIs) have been launched to treat EPO-deficiency anemia in patients with kidney disease. However, the roles of the liver in the HIF-PHI\u2013mediated induction of erythropoiesis and iron mobilization remain controversial. Here, to elucidate the liver contributions to the therapeutic effects of HIF-PHIs, genetically modified mouse lines lacking renal EPO-production ability were analyzed. In the mutant mice, HIF-PHI administration marginally increased plasma EPO concentrations and peripheral erythrocytes by inducing hepatic EPO production. The effects of HIF-PHIs on the mobilization of stored iron and on the suppression of hepatic hepcidin, an inhibitory molecule for iron release from iron-storage cells, were not observed in the mutant mice. These findings demonstrate that adequate induction of EPO mainly in the kidney is essential for achieving the full therapeutic effects of HIF-PHIs, which include hepcidin suppression. The data also show that HIF-PHIs directly induce the expression of duodenal genes related to dietary iron intake. Furthermore, hepatic EPO induction is considered to partially contribute to the erythropoietic effects of HIF-PHIs but to be insufficient to compensate for the abundant EPO induction by the kidneys.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023009798","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T15:59:40Z","timestamp":1683302380000},"page":"3793-3805","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":25,"title":["Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice"],"prefix":"10.1182","volume":"7","author":[{"given":"Taku","family":"Nakai","sequence":"first","affiliation":[{"name":"1Applied Oxygen Physiology Project, New Industry Creation Hatchery Center, Tohoku University, Sendai, Miyagi, Japan"},{"name":"2Division of Oxygen Biology, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Iwamura","sequence":"additional","affiliation":[{"name":"1Applied Oxygen Physiology Project, New Industry Creation Hatchery Center, Tohoku University, Sendai, Miyagi, Japan"},{"name":"2Division of Oxygen Biology, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kato","sequence":"additional","affiliation":[{"name":"1Applied Oxygen Physiology Project, New Industry Creation Hatchery Center, Tohoku University, Sendai, Miyagi, Japan"},{"name":"2Division of Oxygen Biology, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Hirano","sequence":"additional","affiliation":[{"name":"3Department of Molecular Hematology, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8498-1341","authenticated-orcid":false,"given":"Yotaro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"4Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Tomioka","sequence":"additional","affiliation":[{"name":"4Laboratory of Oncology, Pharmacy Practice and Sciences, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9073-9436","authenticated-orcid":false,"given":"Masayuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"5Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6100-3350","authenticated-orcid":false,"given":"Norio","family":"Suzuki","sequence":"additional","affiliation":[{"name":"1Applied Oxygen Physiology Project, New Industry Creation Hatchery Center, Tohoku University, Sendai, Miyagi, Japan"},{"name":"2Division of Oxygen Biology, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"issue":"10","key":"2023080716151074800_bib1","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1182\/blood-2007-10-115857","article-title":"Repression via the GATA box is essential for tissue-specific erythropoietin gene expression","volume":"111","author":"Obara","year":"2008","journal-title":"Blood"},{"issue":"10","key":"2023080716151074800_bib2","doi-asserted-by":"crossref","first-page":"e25839","DOI":"10.1371\/journal.pone.0025839","article-title":"Isolation and characterization of renal erythropoietin-producing cells from genetically produced anemia mice","volume":"6","author":"Pan","year":"2011","journal-title":"PLoS One"},{"issue":"22","key":"2023080716151074800_bib3","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1073\/pnas.84.22.7972","article-title":"The regulated expression of erythropoietin by two human hepatoma cell lines","volume":"84","author":"Goldberg","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2023080716151074800_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1620\/tjem.235.233","article-title":"Erythropoietin gene expression: developmental-stage specificity, cell-type specificity, and hypoxia inducibility","volume":"235","author":"Suzuki","year":"2015","journal-title":"Tohoku J Exp Med"},{"issue":"9","key":"2023080716151074800_bib5","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.90.9.4304","article-title":"General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"2023080716151074800_bib6","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1128\/MCB.00161-15","article-title":"Hypoxia signaling cascade for erythropoietin production in hepatocytes","volume":"35","author":"Tojo","year":"2015","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2023080716151074800_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1681\/ASN.2014121184","article-title":"Erythropoietin synthesis in renal myofibroblasts is restored by activation of hypoxia signaling","volume":"27","author":"Souma","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"2023080716151074800_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.yexcr.2018.03.020","article-title":"HIF-dependent and reversible nucleosome disassembly in hypoxia-inducible gene promoters","volume":"366","author":"Suzuki","year":"2018","journal-title":"Exp Cell Res"},{"issue":"8","key":"2023080716151074800_bib9","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1113\/jphysiol.2013.251470","article-title":"Oxygen sensing and hypoxia signaling pathways in animals: the implications of physiology for cancer","volume":"591","author":"Ratcliffe","year":"2013","journal-title":"J\u00a0Physiol"},{"issue":"3","key":"2023080716151074800_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5414\/CN110749","article-title":"Sufficient liver erythropoietin synthesis is induced in hemodialysis patients not requiring erythropoiesis-stimulating agents","volume":"98","author":"Yanagawa","year":"2022","journal-title":"Clin Nephrol"},{"issue":"8","key":"2023080716151074800_bib11","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1681\/ASN.2015050508","article-title":"Increased synthesis of liver erythropoietin with CKD","volume":"27","author":"De Seigneux","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"2023080716151074800_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jpba.2013.04.009","article-title":"Patients with anaemia can shift from kidney to liver production of erythropoietin as shown by glycoform analysis","volume":"81-82","author":"Lonnberg","year":"2013","journal-title":"J\u00a0Pharm Biomed Anal"},{"issue":"5","key":"2023080716151074800_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ki.2011.179","article-title":"Pattern of resistance to erythropoietin-stimulating agents in chronic kidney disease","volume":"80","author":"Bamgbola","year":"2011","journal-title":"Kidney Int"},{"issue":"1","key":"2023080716151074800_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/cc.7.1.5145","article-title":"Role of the hypoxia inducible factors HIF in iron metabolism","volume":"7","author":"Peyssonnaux","year":"2008","journal-title":"Cell Cycle"},{"issue":"5","key":"2023080716151074800_bib15","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.kint.2018.06.028","article-title":"Iron attenuates erythropoietin production by decreasing hypoxia-inducible transcription factor 2a concentrations in renal interstitial fibroblasts","volume":"94","author":"Suzuki","year":"2018","journal-title":"Kidney Int"},{"key":"2023080716151074800_bib16","doi-asserted-by":"crossref","first-page":"114939","DOI":"10.1016\/j.bcp.2022.114939","article-title":"Esterification promotest he intracellular accumulation of roxadustat, an activator of hypoxia-inducible factors, to extend its effective duration","volume":"197","author":"Nakai","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2023080716151074800_bib17","doi-asserted-by":"crossref","first-page":"e13826","DOI":"10.1111\/apha.13826","article-title":"EPO synthesis induced by HIF-PHD inhibition is dependent on myofibroblast transdifferentiation and colocalizes with non-injured nephron segments in murine kidney fibrosis","volume":"235","author":"Kobayashi","year":"2022","journal-title":"Acta Physiol"},{"issue":"5","key":"2023080716151074800_bib18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI38499","article-title":"HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice","volume":"119","author":"Mastrogiannaki","year":"2009","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"2023080716151074800_bib19","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1053\/j.gastro.2011.03.007","article-title":"Hypoxia-inducible factor-2a mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice","volume":"140","author":"Taylor","year":"2011","journal-title":"Gastroenterology"},{"issue":"5704","key":"2023080716151074800_bib20","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"issue":"9","key":"2023080716151074800_bib21","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"2023080716151074800_bib22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat Genet"},{"issue":"12","key":"2023080716151074800_bib23","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2023080716151074800_bib24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/jcpt.13385","article-title":"Long-term efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in anaemia of chronic kidney disease: a meta-analysis including 13,146 patients","volume":"46","author":"Chen","year":"2021","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"2","key":"2023080716151074800_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/nep.13835","article-title":"Recommendations by the Asian Pacific Society of Nephrology (ASPN) on the appropriate use of HIF-PH inhibitors","volume":"26","author":"Yap","year":"2021","journal-title":"Nephrology"},{"issue":"1","key":"2023080716151074800_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41467-017-00500-z","article-title":"Hepcidin is regulated by promoter-associated histone acetylation and HDAC3","volume":"8","author":"Pasricha","year":"2017","journal-title":"Nat Commun"},{"issue":"12","key":"2023080716151074800_bib27","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1172\/JCI63924","article-title":"Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis","volume":"122","author":"Liu","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"2023080716151074800_bib28","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/ncomms2950","article-title":"A\u00a0mouse model of adult-onset anaemia due to erythropoietin deficiency","volume":"4","author":"Yamazaki","year":"2013","journal-title":"Nat Commun"},{"issue":"4","key":"2023080716151074800_bib29","doi-asserted-by":"crossref","first-page":"e00451-16","DOI":"10.1128\/MCB.00451-16","article-title":"Renal anemia model mouse established by transgenic rescue with an erythropoietin gene lacking kidney-specific regulatory elements","volume":"37","author":"Hirano","year":"2017","journal-title":"Mol Cell Biol"},{"issue":"9","key":"2023080716151074800_bib30","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.3324\/haematol.2015.140814","article-title":"Efficacy estimation of erythropoiesis-stimulating agents using erythropoietin-deficiency anemic mice","volume":"101","author":"Suzuki","year":"2016","journal-title":"Haematologica"},{"issue":"6","key":"2023080716151074800_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3324\/haematol.2011.056119","article-title":"Hepatic hypoxia-inducible factor-2 downregulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis","volume":"97","author":"Mastrogiannaki","year":"2012","journal-title":"Haematologica"},{"issue":"7","key":"2023080716151074800_bib32","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI31370","article-title":"Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)","volume":"117","author":"Peyssonnaux","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"2023080716151074800_bib33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jhep.2007.12.021","article-title":"2-Oxyglutarate-depedent oxygenase control hepcidin gene expression","volume":"48","author":"Braliou","year":"2008","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"2023080716151074800_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.exphem.2016.02.005","article-title":"Quantitative analysis of dietary iron utilization for erythropoiesis in response to body iron status","volume":"44","author":"Matsuo-Tezuka","year":"2016","journal-title":"Exp Hematol"},{"key":"2023080716151074800_bib35","doi-asserted-by":"crossref","first-page":"172532","DOI":"10.1016\/j.ejphar.2019.172532","article-title":"JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, stabilizes HIF-a protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor","volume":"859","author":"Fukui","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"2023080716151074800_bib36","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fgene.2019.01134","article-title":"Alteration of the DNA methylation signature of renal erythropoietin-producing cells govern the sensitivity to drugs targeting the hypoxia-response pathway in kidney disease progression","volume":"10","author":"Sato","year":"2019","journal-title":"Front Genet"},{"issue":"3","key":"2023080716151074800_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOH.0000000000000494","article-title":"New insights into the links between hypoxia and iron homeostasis","volume":"26","author":"Renassia","year":"2019","journal-title":"Curr Opin Hematol"},{"issue":"12","key":"2023080716151074800_bib38","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1681\/ASN.2010010116","article-title":"Inhibition of prolyl hydroxylases increase erythropoietin production in ESRD","volume":"21","author":"Bernhardt","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"2023080716151074800_bib39","doi-asserted-by":"crossref","first-page":"119075","DOI":"10.1016\/j.lfs.2021.119075","article-title":"Defining the functionally sufficient regulatory region and liver-specific roles of the erythropoietin gene by transgene complementation","volume":"269","author":"Yamazaki","year":"2021","journal-title":"Life Sci"},{"issue":"18","key":"2023080716151074800_bib40","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1128\/MCB.05463-11","article-title":"Specific contribution of the erythropoietin gene 3\u2019 enhancer to hepatic erythropoiesis after late embryonic stages","volume":"31","author":"Suzuki","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"12","key":"2023080716151074800_bib41","doi-asserted-by":"crossref","first-page":"e14485","DOI":"10.14814\/phy2.14485","article-title":"Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation","volume":"8","author":"Yasuoka","year":"2020","journal-title":"Physiol Rep"},{"issue":"6","key":"2023080716151074800_bib42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00421-014-2844-7","article-title":"Kidney-synthesized erythropoietin is the main source for the hypoxia-induced increase in plasma erythropoietin in adult humans","volume":"114","author":"Lundby","year":"2014","journal-title":"Eur J Appl Physiol"},{"issue":"3","key":"2023080716151074800_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000492181","article-title":"Novel compound induces erythropoietin secretion through liver effects in chronic kidney disease patients and healthy volunteers","volume":"48","author":"Shinfuku","year":"2018","journal-title":"Am J Nephrol"},{"issue":"3","key":"2023080716151074800_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/jpet.119.258731","article-title":"TP0463518, a novel prolyl hydroxylase inhibitor, specifically induces erythropoietin production in the liver","volume":"371","author":"Kato","year":"2019","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"21","key":"2023080716151074800_bib45","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1128\/MCB.00331-09","article-title":"A\u00a0feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxia response in\u00a0vivo","volume":"29","author":"Minamishima","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"16","key":"2023080716151074800_bib46","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood-2012-07-441824","article-title":"Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis","volume":"120","author":"Laitala","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2023080716151074800_bib47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jphs.2020.09.004","article-title":"Effects of post-renal anemia treatment with the HIF-PHD inhibitor molidustat on adenine-induced renal anemia and kidney disease in mice","volume":"144","author":"Li","year":"2020","journal-title":"J\u00a0Pharmacol Sci"},{"issue":"Suppl 3","key":"2023080716151074800_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2362.2005.01528.x","article-title":"Hyporesponsiveness to erythropoietic therapy due to chronic inflammation","volume":"35","author":"Macdougall","year":"2005","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"2023080716151074800_bib49","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI0215686","article-title":"The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation","volume":"110","author":"Nicolas","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"2023080716151074800_bib50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.kint.2021.04.030","article-title":"Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23","volume":"100","author":"Ikeda","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"2023080716151074800_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000504850","article-title":"Treatment of renal anemia with roxadustat: advantages and achievement","volume":"6","author":"Li","year":"2020","journal-title":"Kidney Dis"},{"issue":"4","key":"2023080716151074800_bib52","doi-asserted-by":"crossref","first-page":"R330","DOI":"10.1152\/ajpregu.00410.2014","article-title":"Erythropoietin\u2019s inhibiting impact on hepcidin expression occurs indirectly","volume":"308","author":"Gammella","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"2023080716151074800_bib53","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1096\/fj.201801855R","article-title":"Hyperglycemia promotes microvillus membrane expression of DMT1 in intestinal epithelial cells in a PKC\u03b1-dependent manner","volume":"33","author":"Zhao","year":"2019","journal-title":"FASEB J"},{"issue":"1","key":"2023080716151074800_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1172\/JCI122359","article-title":"Hepatic hepcidin\/intestinal HIF-2\u03b1 axis maintains iron absorption during iron deficiency and overload","volume":"129","author":"Schwartz","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"2023080716151074800_bib55","doi-asserted-by":"crossref","first-page":"C350","DOI":"10.1152\/ajpcell.00191.2015","article-title":"Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A review in the theme: cellular responses to hypoxia","volume":"309","author":"Zheng","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"2023080716151074800_bib56","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/gast.2002.35353","article-title":"Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats","volume":"123","author":"Frazer","year":"2002","journal-title":"Gastroenterology"},{"issue":"15","key":"2023080716151074800_bib57","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood.2020010562","article-title":"Iron homeostasis during anemia of inflammation: a prospective study of patients with tuberculosis","volume":"138","author":"Cercamondi","year":"2021","journal-title":"Blood"},{"issue":"5","key":"2023080716151074800_bib58","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","article-title":"HIF-1alpha is essential for myeloid cell-mediated inflammation","volume":"112","author":"Cramer","year":"2003","journal-title":"Cell"},{"issue":"2","key":"2023080716151074800_bib59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrd2761","article-title":"Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease","volume":"8","author":"Fraisl","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"2023080716151074800_bib60","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1039\/C7SC02103H","article-title":"Molecular and cellular mechanisms of HIF-prolyl hydroxylase inhibitors in clinical trials","volume":"8","author":"Yeh","year":"2017","journal-title":"Chem Sci"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/3793\/2069585\/blooda_adv-2023-009798-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/15\/3793\/2069585\/blooda_adv-2023-009798-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T12:15:46Z","timestamp":1691410546000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/15\/3793\/495682\/Drugs-activating-hypoxia-inducible-factors-correct"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":60,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,8,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023009798","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]}}}